ClinicalTrials.gov
public full text
Public Domain
Use of Functional MRI to Assess Functional Hypothalamic Activation in Response to Diazoxide
The goal of this study is to determine whether metabolic control centers in the brain can be activated in patients with type 2 diabetes (T2D) as compared to non-diabetic individuals. This is important since people with diabetes have inappropriately high production of glucose, which could be at least in part due to impaired activation of important brain centers.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Functional Magnetic Resonance Imaging of Brain Activity in Patients With Painful Diabetic Neuropathy#832598
- Psilocybin-facilitated Treatment for Cocaine Use#894728
- Hyperglycemia associated brain dysfunction: rodent models for studying diabetic cognitive deficits#784497
- Clinical and Neurobehavioral Changes With Weight Loss Drug Discontinuation and Reinitiation#1151910
- Neurobiological Substrate of Social Context on Cognitive Control in Drug Users#807849
Record · ID 846827
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive